Clinical Trials Directory

Trials / Completed

CompletedNCT04620941

Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated Pneumonia

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Muğla Sıtkı Koçman University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers

Summary

In this study, the utility of changes in the ratio of Ret-He and NLR as an early inflammation marker for VAP will be evaluated.

Detailed description

Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections in the intensive care unit, affecting one third of patients requiring mechanical ventilation for a noninfectious reason. In the case of inflammation, iron retention increases in the reticuloendothelial system cells; hemoglobin (Hb) synthesis is reduced. It has been reported that the ratio of reticulocyte / hemoglobin (Ret-He) decreases in the early period in community-acquired pneumonia patients and may be a guide as a marker of inflammation. In addition, the neutrophil / lymphocyte ratio (NLR) is a parameter studied in the hemogram panel. It provides a clue to both the presence of infection and the focus of the infection. In this study, the utility of changes in the ratio of Ret-He and NLR as an early inflammation marker for VAP will be evaluated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTreticulocyte/hemoglobin (Ret-He) ratioRet-He values will be studied on the day (1st day), 4th and 7th days of the diagnosis of ventilator-associated pneumonia in patients hospitalized in the intensive care unit.

Timeline

Start date
2022-02-21
Primary completion
2023-09-21
Completion
2023-12-21
First posted
2020-11-09
Last updated
2024-11-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04620941. Inclusion in this directory is not an endorsement.